Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 55289-488

3 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 55289-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (55289488)

Image (55289488)
Label for Triamterene and Hydrochlorothiazide tablets 75 mg/50 mg by PD-Rx Pharmaceuticals, Inc. The package contains 15 tablets. The label shows the NDC 55289-488-15, lot number K19B99, and expiration date 11/2021. It includes dosage instructions placeholders and warnings such as keeping out of reach of children and avoiding prolonged sun exposure.*
FDA Label Image

Image 1

Image 1
Chemical structure of Triamterene, one of the active ingredients in Triamterene and Hydrochlorothiazide tablets. The diagram shows the molecular framework and functional groups of Triamterene.*
FDA Label Image

Image 2

Image 2
Chemical structure diagram of the active ingredient in Triamterene and Hydrochlorothiazide, showing the molecular layout with key functional groups including sulfonamide, chlorine, and amine groups attached to a benzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.